Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by bull8888on Mar 30, 2007 3:22pm
280 Views
Post# 12521443

RE: what Don and Theresa can and should do

RE: what Don and Theresa can and should doGuys, good discussion today. Always interesting to read different points of view. I think a lot of the different views are based on the difference on when and for what price and purpose people acquired this stock at. For those that bought recently at between $16 - $29, they were perhaps expecting a buyout to happen pretty quick. They want news now so they can move onto the next sure thing. They are impatient. That is a natural reaction. But if you have been in like I have, for 5 years, you have a lower entry point and fewer fears. My goal since my initial purchase was to wait for a buyout. I knew then and still believe and accept the risk that it will be all or nothing. I am OK with that. I have grown to trust management, and believe they are working on the best possible deal for S/H's. Don't forget who the largest S/H's are. I think the SP will hover in the $14 - $20 range until we are closer to a buyout. I believe they will do what they need to do to bring the SP up to an appropriate level when the time is right. I also believe that they have a support plan in place in case the SP drops below a certain point, say $12. There is not much management can tell us know. We have to be patient. They have already dropped us a little carrot in the NR of last week. I am very comfortable at this point, knowing that the buyout chance gets closer every day. Which is why I entered this stock in the 1st place. I am more comfortable here than at $29, as now the upside is far greater than the downside. Having said that, I wish we still were at $29, I could deal with that stress! Good luck, stay long and have a great weekend. IMHO
Bullboard Posts